1047P Lung-MAP S1800A: Exploratory analysis of prior immunotherapy outcomes on OS with ramucirumab plus pembrolizumab for NSCLC with PD on prior ICI
Reckamp, K., Redman, M.W., Dragnev, K., Villaruz, L., Faller, B., Al Baghdadi, T., Hines, S., Minichiello, K., Gandara, D.R., Kelly, K., Herbst, R.S.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
OA04.01 A Phase III Randomized Study of Nivolumab/Ipilimumab vs Nivolumab for Previously Treated Stage IV Squamous Cell Lung Cancer
Bazhenova, L., Redman, M., Gettinger, S., Hirsch, F.R., Mack, P., Schwartz, L., Gandara, D., Bradley, J., Stinchcombe, T., Leighl, N., Ramalingam, S., Tavernier, S., Minichiello, K., Kelly, K., Papadimitrakopoulou, V., Herbst, R.
Published in Journal of thoracic oncology (01.10.2019)
Published in Journal of thoracic oncology (01.10.2019)
Get full text
Journal Article